“Machines & Medicine”: new podcast from Syntegon covers all important pharma topics

  • Conversations around everything related to the pharmaceutical industry
  • Six episodes available on Spotify and YouTube: from Annex 1 to sustainability
  • Many more exciting topics and guests from the industry planned for 2024

Waiblingen (Germany), December 13, 2023. The pharmaceutical industry faces regulations and challenges like no other. Drug manufacturers are subject to the highest quality and efficacy standards, all the while under increasing pressure to be flexible and develop fast time-to-market strategies for newly developed drugs. To break these complex topics down into an easily digestible format, Syntegon has launched a new podcast series “Machines & Medicine”. Every six to eight weeks, Dr. Laura Moody, Director of Product Management Pharma North America, engages with experts from pharmaceutical manufacturing companies to discuss real issues in the industry. In the 30-minute episodes, the host and her guests provide revealing and exciting insights into the topics and trends that currently matter most to pharmaceutical manufacturers and beyond.

Informative, educational, and casual

“Machines & Medicine” was created as a global format for conversations related to pharmaceutical manufacturing from a machine builder point of view. The first six episodes focus on Annex 1, sustainability, nutraceuticals, parenteral drug manufacturing, robotics, and isolators. “While we started with a lens on equipment, the topics don’t stop there. Our informative yet casual atmosphere fosters discussions around everything related to pharma, with a little laughter along the way,” Laura Moody explains. Every episode includes in-depth information on a carefully selected topic, followed by a short trivia round at the end. “I have learned something new from each and every one of my guests this year. For me, that’s the biggest highlight: continuous learning.”

Many more topics to be discovered in 2024

The “Machines & Medicine” podcast is available on Spotify and YouTube. The series will be continued in 2024, including subjects like facility design, continuous manufacturing, materials science, and commodity idiosyncrasies. Listeners will also get to know more industry leaders on the podcast, who will share a wider breadth of knowledge across their areas of expertise. “I’m looking forward to recording the next episodes and learning even more exciting details about everything related to pharmaceutical manufacturing,” Laura Moody concludes.

View all episodes of “Machines & Medicine” here.

Company: Syntegon Technology GmbH

Processing and packaging for a better life – this is what 5,800 Syntegon employees work for everyday. Be it with individual machines, systems, or services, Syntegon helps its customers in the global pharmaceutical and food industries to improve people's lives. The company, which is headquartered in Waiblingen, Germany, looks back on more than 160 years of experience and achieved annual sales of 1.4 billion EUR in 2021. In the pharma sector, the company’s intelligent solutions enable the safe and high-quality production, processing, filling, inspection, and packaging of liquid and solid pharmaceuticals. In the food industry, Syntegon’s flexible and reliable technologies produce and pack confectionery, dry food, frozen food, and dairy products. With 1,100 service experts and a comprehensive service portfolio throughout the entire machine lifecycle from spare parts management to digital line optimization, Syntegon lays the foundation for smooth production processes for all customers. More than 30 sites in almost 20 countries keep a firm eye on Syntegon’s impact on the environment and society. Syntegon is a leader in the development of sustainable packaging solutions, reduces the energy consumption of its machines and pursues ambitious goals to lower its emissions.www.syntegon.com

Send Enquiry for this story

By submitting this form you are giving a consent to Worldpharmatoday.com to store your submitted information.
See our Privacy Policy to learn more about how we use data.